KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Total Liabilities: 2009-2025

Historic Total Liabilities for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to $413.5 million.

  • Acadia Pharmaceuticals' Total Liabilities rose 3.46% to $413.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $413.5 million, marking a year-over-year increase of 3.46%. This contributed to the annual value of $455.0 million for FY2024, which is 43.43% up from last year.
  • Acadia Pharmaceuticals' Total Liabilities amounted to $413.5 million in Q3 2025, which was up 2.56% from $403.2 million recorded in Q2 2025.
  • In the past 5 years, Acadia Pharmaceuticals' Total Liabilities ranged from a high of $455.0 million in Q4 2024 and a low of $150.7 million during Q3 2021.
  • Moreover, its 3-year median value for Total Liabilities was $391.1 million (2024), whereas its average is $358.4 million.
  • Per our database at Business Quant, Acadia Pharmaceuticals' Total Liabilities spiked by 69.27% in 2023 and then dropped by 6.12% in 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Total Liabilities (Quarterly) stood at $159.2 million in 2021, then grew by 17.69% to $187.4 million in 2022, then surged by 69.27% to $317.2 million in 2023, then skyrocketed by 43.43% to $455.0 million in 2024, then grew by 3.46% to $413.5 million in 2025.
  • Its Total Liabilities was $413.5 million in Q3 2025, compared to $403.2 million in Q2 2025 and $367.1 million in Q1 2025.